The average one-year price target for Oruka Therapeutics (NasdaqGM:ORKA) has been revised to $56.44 / share. This is an increase of 12.54% from the prior estimate of $50.15 dated December 18, 2025.

The 52nd edition of the legendary Rosendale Viking Run took place on Sunday, December 28, starting from the corner of ...

Carnival ( CCL 0.59%) is the longtime leader in the cruise industry. According to the website Cruise Market Watch, nearly 42% ...

The Blooming Prairie boys basketball team beat Hayfield in their two regular season meetings in both the 2023-24 and 2024-25 ...

A new housing development coming to Reynolds Township in Montcalm County is set to be built with an eye on affordability.

Panthers place 3rd at dual meet ...

The market is fueled by AI power density and EV electrification. With ultra-low ESR capabilities, conductive polymers are ...

The B-21 Raider is not just a new bomber, it is a calculated force structure designed to hold every major adversary at risk at the same time. This breakdown explains the mathematics, stealth, range, ...

The West Wilkes varsity boys basketball team rallied to win its first game of the season Tuesday, clipping West Iredell, ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $35.32, marking a -3.13% move from the previous day.

Dallas Cowboys defensive tackle Quinnen Williams (92) intercepts a pass during the first half of an NFL football game against ...